| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.08 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.08 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.14 | 0.08 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.09 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.09 |